Socially-run doctors under the tide of expansion of public hospitals: the battle for giants, the battle for people, and the development of specialty supplements

This is the worst of times and the best of times.

40 years of ups and downs in running a medical institution in society is becoming a must for pharmaceutical and equipment companies.

Twelve years ago, Guan Weili, the executive director of the Chinese Hospital Association and the chairman of the private hospital branch of the Chinese Hospital Association When he first heard that a multinational medical device group was planning to set up a non-public medical business, he was surprised and applauded.

Guan Weili recalled that at that time, foreign-funded companies, whether it was medicine or equipment, all focused on domestic public hospitals. Non-public medical care is weak.

“Especially large foreign equipment companies disdain non-public medical care because Many private medical institutions do not have the purchasing power.”He told the health community.

At that time, GE Healthcare established a special The medical business department has more than 100 people. Dai Hongdong, vice president of GE Healthcare China and general manager of non-public medical business, recalled to the health industry: “At first we were not sure what the future of non-public medical care in China would look like.”

But from the general trend, GE Healthcare sees two opportunities: On the one hand, compared with developed countries in Europe and America, non-public healthcare already has a mature model, which China can learn from. On the other hand, it is impossible for public medical institutions to meet all medical needs, and it is necessary to supplement non-public medical care.

Nowadays, this uncertain “chess” move has been operated with the scale of non-public medical care in China , has become a place where medicine and weapons compete.

According to the “Statistical Bulletin of my country’s Health Development”, public hospitals were still the main body of medical and health institutions in 2010. , the number is about 2 times that of private medical care, and the number of beds is nearly 10 times that of private medical care. In 2021, the number of non-public medical institutions has already caught up, with 24,700 private hospitals more than twice as many as 11,800 public hospitals.

With the rapid growth of non-public medical care, it is the “enthusiasm” that pharmaceutical and device companies have continued to increase over the past decade or so . In 2013, Haier’s Industrial Finance and Medical Division was established; in 2014, Philips(China)Healthcare released the first private hospital cooperation plan; in 2018, Mindray Medical Announced that 30% of its revenue comes from non-public healthcare; in 2019, Siemens Healthcare announced its non-public healthcare strategy and solutions for the first time; in 2021, Baden Healthcare and Mindray Healthcare reached a partnership to serve the digital collection needs of non-public healthcare.

See Weizhi. Why has non-public medical care become a must for pharmaceutical equipment companies? This is an inevitable choice under the wave of China’s medical reform, and it is also a testament to the future development trend of non-public medical care.